NO20024194L - Nytt selvemulgerende legemiddelavleveringssystem - Google Patents

Nytt selvemulgerende legemiddelavleveringssystem

Info

Publication number
NO20024194L
NO20024194L NO20024194A NO20024194A NO20024194L NO 20024194 L NO20024194 L NO 20024194L NO 20024194 A NO20024194 A NO 20024194A NO 20024194 A NO20024194 A NO 20024194A NO 20024194 L NO20024194 L NO 20024194L
Authority
NO
Norway
Prior art keywords
delivery system
drug delivery
emulsifying drug
new self
self
Prior art date
Application number
NO20024194A
Other languages
English (en)
Other versions
NO20024194D0 (no
NO331921B1 (no
Inventor
Christina Holmberg
Britta Siekmann
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20024194D0 publication Critical patent/NO20024194D0/no
Publication of NO20024194L publication Critical patent/NO20024194L/no
Publication of NO331921B1 publication Critical patent/NO331921B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20024194A 2000-03-08 2002-09-03 Nytt selvemulgerende legemiddelavleveringssystem NO331921B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0000774A SE0000774D0 (sv) 2000-03-08 2000-03-08 New formulation
PCT/SE2001/000466 WO2001066087A1 (en) 2000-03-08 2001-03-06 New self emulsifying drug delivery system

Publications (3)

Publication Number Publication Date
NO20024194D0 NO20024194D0 (no) 2002-09-03
NO20024194L true NO20024194L (no) 2002-09-03
NO331921B1 NO331921B1 (no) 2012-04-30

Family

ID=20278740

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024194A NO331921B1 (no) 2000-03-08 2002-09-03 Nytt selvemulgerende legemiddelavleveringssystem

Country Status (29)

Country Link
US (2) US7736666B2 (no)
EP (1) EP1267831B1 (no)
JP (1) JP4656479B2 (no)
KR (1) KR100771318B1 (no)
CN (1) CN1283229C (no)
AR (1) AR027554A1 (no)
AT (1) ATE311173T1 (no)
AU (2) AU3787501A (no)
BR (1) BR0109012B1 (no)
CA (1) CA2401857A1 (no)
CZ (1) CZ303524B6 (no)
DE (1) DE60115402T2 (no)
DK (1) DK1267831T3 (no)
EE (1) EE200200483A (no)
ES (1) ES2253354T3 (no)
HK (1) HK1053795A1 (no)
HU (1) HU229103B1 (no)
IL (1) IL151380A0 (no)
IS (1) IS6538A (no)
MX (1) MXPA02008658A (no)
MY (1) MY137749A (no)
NO (1) NO331921B1 (no)
RU (1) RU2275908C2 (no)
SE (1) SE0000774D0 (no)
SI (1) SI1267831T1 (no)
SK (1) SK285749B6 (no)
UA (1) UA76098C2 (no)
WO (1) WO2001066087A1 (no)
ZA (1) ZA200207109B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
SE0102993D0 (sv) * 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
ITMI20021392A1 (it) * 2002-06-25 2003-12-29 Nicox Sa Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
US8802116B2 (en) 2003-02-27 2014-08-12 Novasel Australia Pty. Ltd. Poloxamer emulsion preparations
AU2003900887A0 (en) * 2003-02-27 2003-03-13 Novasel Australia Pty Ltd Poloxamer emulsion preparations
DE10353937A1 (de) * 2003-11-18 2005-06-30 Fresenius Medical Care Deutschland Gmbh Vorrichtung zur Übertragung einer Referenzflüssigkeit in ein Messgerät, Messgerät mit einer solchen Vorrichtung und Verfahren zur Übertragung einer Referenzflüssigkeit in ein Messgerät
GB0402679D0 (en) * 2004-02-06 2004-03-10 Novartis Ag Organic compounds
JP2007536268A (ja) * 2004-05-06 2007-12-13 エミスフェアー・テクノロジーズ・インク 固体剤形の湿性ヘパリン
JP5254610B2 (ja) 2004-05-14 2013-08-07 エミスフェアー・テクノロジーズ・インク 活性薬剤を送達するための化合物および組成物
KR100654617B1 (ko) * 2004-09-23 2006-12-08 정해현 스틱이 내장된 커피믹스 팩과 커피믹스 박스
MX2008001213A (es) * 2005-07-26 2008-03-24 Nicox Sa Formulacion farmaceutica de derivados nitrooxi de farmacos anti-inflamatorios no esteroidales.
MX2010010214A (es) 2008-03-20 2010-12-21 Virun Inc Derivados de vitamina e y sus usos.
CA2718231C (en) 2008-03-20 2013-02-05 Virun, Inc. Emulsions including a peg-derivative of tocopherol
WO2011047259A1 (en) 2009-10-16 2011-04-21 Glaxosmithkline Llc Compositions
US8741373B2 (en) 2010-06-21 2014-06-03 Virun, Inc. Compositions containing non-polar compounds
US9968557B1 (en) 2011-02-09 2018-05-15 Florida A&M University Method of preparing modified multilayered microstructures with enhanced oral bioavailability
KR20240076240A (ko) * 2022-11-23 2024-05-30 (주) 바이오인프라생명과학 더블 에멀젼 구조의 초음파 감응형 약물전달체를 생성하는 방법

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
CY1398A (en) 1981-09-04 1987-12-18 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
JPS59227870A (ja) 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
US4554276A (en) 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4522826A (en) 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
US4766117A (en) 1984-10-11 1988-08-23 Pfizer Inc. Antiinflammatory compositions and methods
US4704278A (en) 1984-10-17 1987-11-03 American Home Products Corp (Del) Fluidized magaldrate suspension
US4676984A (en) 1985-08-14 1987-06-30 American Home Products Corp. Rehydratable antacid composition
US5037815A (en) 1986-03-04 1991-08-06 Bristol-Myers Squibb Co. Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
US5043358A (en) 1986-03-04 1991-08-27 Bristol-Myers Squibb Company Gastroprotective process
US4757060A (en) 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
US4965065A (en) 1986-04-29 1990-10-23 Bristol-Myers Squibb Company Gastroprotective process and compositions
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5260333A (en) 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
GB8630273D0 (en) 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
EP0320550A1 (en) 1987-12-18 1989-06-21 Bristol-Myers Company Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent
SE8804629D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US5204118A (en) 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
IN171746B (no) 1989-11-02 1992-12-26 Mcneil Ppc Inc
CA2104684A1 (en) 1991-03-04 1992-09-05 Mahdi B. Fawzi Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
DE4131678A1 (de) 1991-04-13 1992-10-15 Beiersdorf Ag Stabile multiple emulsionen
DE69228738D1 (de) 1991-12-06 1999-04-29 Glaxo Group Ltd Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
AU3247593A (en) 1991-12-20 1993-07-28 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
US5294433A (en) 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
IT1256345B (it) 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
EP0663839A4 (en) 1992-09-29 1998-06-03 Merck & Co Inc COMBINATIONS OF IBUPROFEN WITH A H2 ANTAGONIST.
IT1256450B (it) 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
US5686105A (en) 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
DK66493D0 (da) 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
SE9302396D0 (sv) 1993-07-09 1993-07-09 Ab Astra A novel compound form
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
FR2710535B1 (fr) 1993-09-30 1995-11-24 Gattefosse Ets Sa Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
US6054136A (en) 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
AU678063B2 (en) * 1993-10-06 1997-05-15 Nicox S.A. Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
US5514663A (en) 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
JP3725542B2 (ja) 1993-10-19 2005-12-14 大正製薬株式会社 ピコサルフェート剤形
US6025395A (en) 1994-04-15 2000-02-15 Duke University Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
US5643960A (en) 1994-04-15 1997-07-01 Duke University Method of delaying onset of alzheimer's disease symptoms
US5861426A (en) * 1994-05-10 1999-01-19 Nicox S.A. Nitro compounds of the formula A-Xi -NO2 and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
CZ289804B6 (cs) 1994-07-08 2002-04-17 Astrazeneca Ab Multijednotková tabletovaná dávková forma I
SE9500478D0 (sv) 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
AU692255B2 (en) * 1995-04-24 1998-06-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
US5955451A (en) 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
EP0760237A1 (en) 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
EP0941101A1 (en) 1996-11-22 1999-09-15 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
US6160020A (en) 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
SE510666C2 (sv) 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
ES2184310T3 (es) * 1997-07-29 2003-04-01 Upjohn Co Formulacion autoemulsionante para compuestos lipofilos acidos.
ATE252892T1 (de) 1997-09-11 2003-11-15 Nycomed Danmark Aps Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids)
EP1032425A1 (en) 1997-10-31 2000-09-06 Monsanto Company Gellan gum tablet coating
EP1056457A4 (en) 1998-01-30 2006-10-25 Sepracor Inc S-LANSOPRAZOLE COMPOSITIONS AND METHODS OF USE
EP1056456A4 (en) 1998-01-30 2006-10-25 Sepracor Inc R-LANSOPRAZOL COMPOSITIONS AND TREATMENTS THEREFOR
WO1999056727A2 (en) * 1998-05-07 1999-11-11 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
EP0984012A3 (en) 1998-08-31 2001-01-10 Pfizer Products Inc. Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
ID28275A (id) 1998-09-28 2001-05-10 Warner Lambert Co Penghantaran kolon dan enterik yang menggunakan kapsul-kapsul hpmc
US6485747B1 (en) 1998-10-30 2002-11-26 Monsanto Company Coated active tablet(s)
KR100602725B1 (ko) * 1998-12-11 2006-07-20 파마솔루션스, 인코포레이티드 물에서 불충분하게 용해되는 약제를 위한 자가-유화용조성물
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
DE60017720T2 (de) 1999-03-31 2006-01-12 Pharmacia & Upjohn Co., Kalamazoo Pharmazeutische emulsionen für retroviral-protease hemmende verbindungen
AU4198899A (en) 1999-05-20 2000-12-12 Par Pharmaceutical, Inc. Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
TWI243672B (en) * 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
US6126816A (en) * 1999-07-14 2000-10-03 Ruiz, Jr.; Reuben F. Wastewater treatment device
US20020102301A1 (en) * 2000-01-13 2002-08-01 Joseph Schwarz Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
US6787164B2 (en) 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US20020044962A1 (en) 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6544556B1 (en) 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
US20020045184A1 (en) 2000-10-02 2002-04-18 Chih-Ming Chen Packaging system
FR2818905A1 (fr) * 2000-12-28 2002-07-05 Cll Pharma Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile
AR036354A1 (es) 2001-08-31 2004-09-01 Takeda Chemical Industries Ltd Preparacion solida
US7467633B2 (en) * 2005-03-10 2008-12-23 Huntsman Petrochemical Corporation Enhanced solubilization using extended chain surfactants

Also Published As

Publication number Publication date
US7736666B2 (en) 2010-06-15
IL151380A0 (en) 2003-04-10
ATE311173T1 (de) 2005-12-15
JP2003525893A (ja) 2003-09-02
MXPA02008658A (es) 2003-02-24
CN1283229C (zh) 2006-11-08
SI1267831T1 (sl) 2006-04-30
DE60115402D1 (de) 2006-01-05
BR0109012A (pt) 2003-06-03
SE0000774D0 (sv) 2000-03-08
EP1267831B1 (en) 2005-11-30
EP1267831A1 (en) 2003-01-02
KR20030011788A (ko) 2003-02-11
CA2401857A1 (en) 2001-09-13
KR100771318B1 (ko) 2007-10-29
US20100266683A1 (en) 2010-10-21
NO20024194D0 (no) 2002-09-03
AU3787501A (en) 2001-09-17
HK1053795A1 (en) 2003-11-07
DE60115402T2 (de) 2006-08-03
JP4656479B2 (ja) 2011-03-23
CZ303524B6 (cs) 2012-11-14
HU229103B1 (en) 2013-07-29
US20030077303A1 (en) 2003-04-24
PL358617A1 (en) 2004-08-09
RU2002122745A (ru) 2004-03-20
NO331921B1 (no) 2012-04-30
AR027554A1 (es) 2003-04-02
CZ20023006A3 (cs) 2003-02-12
MY137749A (en) 2009-03-31
HUP0300539A3 (en) 2003-09-29
BR0109012B1 (pt) 2014-08-26
IS6538A (is) 2002-09-03
HUP0300539A2 (hu) 2003-07-28
EE200200483A (et) 2004-02-16
RU2275908C2 (ru) 2006-05-10
CN1416336A (zh) 2003-05-07
DK1267831T3 (da) 2006-03-20
ZA200207109B (en) 2003-12-04
ES2253354T3 (es) 2006-06-01
AU2001237875B2 (en) 2005-05-12
UA76098C2 (en) 2006-07-17
WO2001066087A1 (en) 2001-09-13
SK12582002A3 (sk) 2003-04-01
SK285749B6 (sk) 2007-07-06

Similar Documents

Publication Publication Date Title
NO20041315L (no) Medikamentavleveringssystem
ATE405630T1 (de) Wirkstoffabgabesysteme
DE60016271D1 (de) Medikamentenzuführvorrichtung
ATE381262T1 (de) Pestizid-abgabesystem
DE60120071D1 (de) Stentanbringungssystem
ATE526973T1 (de) Verbesserte arzneimittelabgabe in transdermalen systemen
NO20030627L (no) Hydrogel-drevet medikament doseringsform
NO20004196D0 (no) Innretninger for legemiddelavlevering
DE60115821D1 (de) Hydraulisches Stenteinbringungssystem
ITTO20010005A0 (it) Formulazione farmaceutica.
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
AU7333601A (en) Drug delivery management system
NO20024194L (no) Nytt selvemulgerende legemiddelavleveringssystem
NL1015859A1 (nl) Farmaceutische preparaten.
DE60126089D1 (de) Verabreichungssystem
DE60217615D1 (de) Inhaltlieferungssystem
HK1077523A1 (en) Proliposomal drug delivery system
ATE386503T1 (de) Neues selbstemulgierendes arzneimittelfreisetzungssystem
IL137559A0 (en) Transdermal drug delivery system
DE10192797D2 (de) Drug-Delivery-Systeme
FR2820311B3 (fr) Distributeur de medicament portatif
IS6163A (is) Lyfjakomplex
GB0029843D0 (en) Drug delivery system
DK1183061T3 (da) Lægemiddelafgivelsessystem
DK1221917T3 (da) Anordning til lægemiddelafgivelse

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: NICOX SCIENCE IRELAND, IE

MM1K Lapsed by not paying the annual fees